156 results on '"Koudstaal, Wouter"'
Search Results
2. Immune age and biological age as determinants of vaccine responsiveness among elderly populations : the Human Immunomics Initiative research program
3. A small-molecule fusion inhibitor of influenza virus is orally active in mice
4. SARS-CoV-2 binding and neutralizing antibody levels after Ad26.COV2.S vaccination predict durable protection in rhesus macaques
5. Biological age in healthy elderly predicts aging-related diseases including dementia
6. Structural Basis for Recognition of a Unique Epitope by a Human Anti-tau Antibody
7. Naturally occurring antibodies isolated from PD patients inhibit synuclein seeding in vitro and recognize Lewy pathology
8. Epitope mapping of diverse influenza Hemagglutinin drug candidates using HDX-MS
9. Protection against H5N1 by multiple immunizations with seasonal influenza vaccine in mice is correlated with H5 cross-reactive antibodies
10. Immunological memory to hyperphosphorylated tau in asymptomatic individuals
11. A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen
12. Human Monoclonal Antibodies for Prophylaxis and Treatment of Influenza
13. Corrigendum: The influenza hemagglutinin stem antibody CR9114: Evidence for a narrow evolutionary path towards universal protection
14. Enhancement of therapeutic potential of a naturally occurring human antibody targeting a phosphorylated Ser422 containing epitope on pathological tau
15. A common antigenic motif recognized by naturally occurring human VH5–51/VL4–1 anti-tau antibodies with distinct functionalities
16. The influenza hemagglutinin stem antibody CR9114: Evidence for a narrow evolutionary path towards universal protection
17. A common solution to group 2 influenza virus neutralization
18. Highly Conserved Protective Epitopes on Influenza B Viruses
19. A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses
20. Pre- and Postexposure Use of Human Monoclonal Antibody against H5N1 and H1N1 Influenza Virus in Mice: Viable Alternative to Oseltamivir
21. VACCINES: A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen
22. Safety and efficacy in geese of a PER.C6-based inactivated West Nile virus vaccine
23. Human Monoclonal Antibodies for Prophylaxis and Treatment of Influenza
24. SARS-CoV-2 binding and neutralizing antibody levels after vaccination with Ad26.COV2.S predict durable protection in rhesus macaques
25. Biological Age in Healthy Elderly Predicts Dementia in the Absence of a Brain Marker
26. Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study
27. Adenovirus types 5 and 35 seroprevalence in AIDS risk groups supports type 35 as a vaccine vector
28. Single-cell Screening Method for the Selection and Recovery of Antibodies with Desired Specificities from Enriched Human Memory B Cell Populations
29. Additional file 1: of A common antigenic motif recognized by naturally occurring human VH5–51/VL4–1 anti-tau antibodies with distinct functionalities
30. Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study.
31. In Vitro Assay for Studying the Aggregation of Tau Protein and Drug Screening
32. Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia
33. Common antigenic motif recognized by human VH5-51/VL4-1 tau antibodies with distinct functionalities
34. In Vitro Neutralization Is Not Predictive of Prophylactic Efficacy of Broadly Neutralizing Monoclonal Antibodies CR6261 and CR9114 against Lethal H2 Influenza Virus Challenge in Mice
35. Additional file 2: Figure S1. of Matrix-M™ adjuvation broadens protection induced by seasonal trivalent virosomal influenza vaccine
36. Additional file 5: Figure S4. of Matrix-M™ adjuvation broadens protection induced by seasonal trivalent virosomal influenza vaccine
37. Additional file 4: Figure S3. of Matrix-M™ adjuvation broadens protection induced by seasonal trivalent virosomal influenza vaccine
38. Additional file 1: Table S1. of Matrix-M™ adjuvation broadens protection induced by seasonal trivalent virosomal influenza vaccine
39. Additional file 6: Figure S5. of Matrix-M™ adjuvation broadens protection induced by seasonal trivalent virosomal influenza vaccine
40. Additional file 3: Figure S2. of Matrix-M™ adjuvation broadens protection induced by seasonal trivalent virosomal influenza vaccine
41. HA Antibody-Mediated FcγRIIIa Activity Is Both Dependent on FcR Engagement and Interactions between HA and Sialic Acids
42. Matrix-M™ adjuvation broadens protection induced by seasonal trivalent virosomal influenza vaccine
43. Transient Humoral Protection against H5N1 Challenge after Seasonal Influenza Vaccination of Humans
44. Mechanisms of Hemagglutinin Targeted Influenza Virus Neutralization
45. A common solution to group 2 influenza virus neutralization
46. Mechanisms of Hemagglutinin Targeted Influenza Virus Neutralization
47. New Class of Monoclonal Antibodies against Severe Influenza: Prophylactic and Therapeutic Efficacy in Ferrets
48. Immunogenicity of Recombinant Adenovirus Serotype 35 Vaccine in the Presence of Pre-Existing Anti-Ad5 Immunity
49. Neutralizing Antibodies and CD8 + T Lymphocytes both Contribute to Immunity to Adenovirus Serotype 5 Vaccine Vectors
50. Quantifying Adenovirus-Neutralizing Antibodies by Luciferase Transgene Detection: Addressing Preexisting Immunity to Vaccine and Gene Therapy Vectors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.